
FDA panel votes unanimously in favor of Horizon’s thyroid eye disease drug
(Reuters) – Independent advisers to the U.S. Food and Drug Administration on Friday voted unanimously in favor of Horizon Therapeutics Plc’s experimental treatment for active thyroid eye disease, taking the …
Read More